Boston Microfluidics develops simple, intuitive, and needle-free blood collection devices designed to greatly simplify and revolutionize blood testing globally. Its mission is to design devices that make it easier for people, and their healthcare providers, to connect to their health, while reducing the barriers that prevent people from getting blood tests.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/27/19 | $17,500,000 | Series A |
Anzu Partners LabCorp | undisclosed |
